Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

NCT: NCT06234995 · RECRUITING

NCT IDNCT06234995
StatusRECRUITING
Start Date2021-08-09
Completion2026-07

Brief Summary

Patients with Parkinson's Disease will be studied before, during, and after a deep brain stimulation implantation procedure to see if the stimulation location and the size of the electrical field produced by subthalamic nucleus (STN) DBS determine the degree to which DBS engages circuits that involve prefrontal cortex executive functions, and therefore have a direct impact on the patient's ability to inhibit actions.

Frequently Asked Questions

What is Cortical Electrophysiology of Response Inhibition in Parkinson's Disease?

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease is a clinical trial registered under NCT06234995. Current status: RECRUITING.

What is the status of NCT06234995?

The current status of NCT06234995 (Cortical Electrophysiology of Response Inhibition in Parkinson's Disease) is: RECRUITING.

When did Cortical Electrophysiology of Response Inhibition in Parkinson's Disease start?

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease started on 2021-08-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑